Vitiligo Clinical Trials

270 clinical trials for Vitiligo across international registries, including 39 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo — RECRUITING · PHASE3
• A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo — RECRUITING · PHASE2
• An Observational Study of Patients With Dermatologic Disease — RECRUITING
• Study of D-2570 in Subjects With Non-Segmental Vitiligo — RECRUITING · PHASE2
• PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents — RECRUITING
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata — RECRUITING
• The Gut and Skin Microbiome in Vitiligo Disease Progression — RECRUITING
• Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo — RECRUITING · PHASE2
• A PHASE 2, RANDOMIZED, 24-WEEK, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF-OF-CONCEPT STUDY TO INVESTIGATE EFFICACY AND SAFETY OF LY4005130 IN ADULT PARTICIPANTS WITH NON-SEGMENTAL VITILIGO — RECRUITING · PHASE2
• Multi-Country, Cross-Sectional Study to Characterize Real-World Burden of Disease in Adolescent and Adult Patients with Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa — RECRUITING
• Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo — RECRUITING · PHASE1
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING PHASE IIB STUDY TO ASSESS THE EFFICACY AND SAFETY OF GIA632 IN ADULT PARTICIPANTS WITH NON-SEGMENTAL VITILIGO FOLLOWED BY AN EXTENSION PERIOD — RECRUITING · PHASE2
• A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo — RECRUITING · PHASE1
• A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE® and Narrow-Band Ultraviolet B (NB-UVB) Light versus NB-UVB Light Alone in the Treatment of Vitiligo — RECRUITING · PHASE3
• Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo — RECRUITING · PHASE4
• A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo — RECRUITING
• Betamethasone Phonophoresis For Vitiligo — RECRUITING · NA
• A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo — RECRUITING · PHASE1
• Acne inversa: research on pathogenesis and preclinical testing of potential therapeutic approaches — RECRUITING
• Making the invisible visible: Use of whole-body photography for early detection and telemonitoring of vitiligo in southern Germany — RECRUITING
• A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE RANGING TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ZASOCITINIB IN PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE2
• Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo — RECRUITING · NA
• Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients — RECRUITING · PHASE4
• Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT — RECRUITING · NA
• Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients — RECRUITING · PHASE4
• Efficacy of Upadacitinib After NECS in Vitiligo — RECRUITING · NA
• Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus — RECRUITING · PHASE2
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, SAFETY, AND EFFICACY STUDY OF RUXOLITINIB CREAM IN PEDIATRIC PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED PHASE 2B TRIAL EVALUATING THE EFFICACY, SAFETY & PHARMACOKINETICS OF VYN201 GEL IN THE TREATMENT OF NON-SEGMENTAL VITILIGO — RECRUITING · PHASE2
• A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF UPADACITINIB IN ADULT AND ADOLESCENT SUBJECTS WITH NON-SEGMENTAL VITILIGO WHO ARE ELIGIBLE FOR SYSTEMIC THERAPY — RECRUITING · PHASE3
• A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTI-CENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB (PF-06651600) IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
• Cross-sectional study on out-of-pocket-costs and psychosocial burden in vitiligo patients and usage of digital media — RECRUITING
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO-CONTROLLED MULTI-CENTER STUDY WITH A DOUBLE-BLIND 52-WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UP/DOSE DOWN TITRATION INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
• A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-6194 IN ADULT PARTICIPANTS WITH NON- SEGMENTAL VITILIGO — RECRUITING · PHASE2
• SELECTIVE TREATMENT OF ORAL POVORCITINIB IN VITILIGO STUDY 2 (STOP V2) A PHASE 3, RANDOMIZED, DOUBLE-BLIND, 52-WEEK, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF POVORCITINIB IN PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
• SELECTIVE TREATMENT OF ORAL POVORCITINIB IN VITILIGO STUDY 1 (STOP V1) A PHASE 3, RANDOMIZED, DOUBLE-BLIND, 52-WEEK, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF POVORCITINIB IN PARTICIPANTS WITH NONSEGMENTAL VITILIGO — RECRUITING · PHASE3
• Skin diseases and the association with addictive diseases — RECRUITING
• A PHASE 2A, PROOF OF CONCEPT, 24-WEEK, PARALLEL GROUP, DOUBLE BLIND, VEHICLE-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ARQ-252 CREAM 0.3% IN SUBJECTS WITH NON SEGMENTAL FACIAL VITILIGO — RECRUITING · PHASE2
• A DOUBLE-BLIND, VEHICLE-CONTROLLED, RANDOMIZED WITHDRAWAL AND TREATMENT EXTENSION STUDY TO ASSESS THE LONG-TERM EFFICACY AND SAFETY OF RUXOLITINIB CREAM IN PARTICIPANTS WITH VITILIGO (TRUE-V LTE) — RECRUITING
• A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo — TERMINATED · PHASE3
• Oral Mini Pulse Dexamethasone in Pediatric Vitiligo — ACTIVE_NOT_RECRUITING · PHASE4
• Vitiligo treatment by targeting TYK2 mediated responses — TERMINATED · PHASE2
• A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo — ACTIVE_NOT_RECRUITING · PHASE1
• CombiVIT Combination approach with ritlecitinib and nbUVB compared to ritlecitinib alone for treating vitiligo Prospective multicentric evaluator blinded interventional study — TERMINATED · PHASE2
• Defining the Role of the Skin Microbiome in Immune-related Adverse Events — TERMINATED · NA
• A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo — ACTIVE_NOT_RECRUITING · PHASE1
• Excimer Lamp Versus Excimer Laser in Vitiligo Treatment — COMPLETED · PHASE3
• A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo — NOT_YET_RECRUITING · PHASE1
• Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo — COMPLETED · PHASE2
• A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo — ACTIVE_NOT_RECRUITING · PHASE3

Refine this search